Xbiotech

NSQ:XBIT · CA98400H1029

BiotechnologySmall

360° View

no current rank

Value—

Price/Sales—

Price/Earnings—

Price/Book65

Dividend Yield1

Growth26

Revenue Growth—

Profit Growth99

Capital Growth82

TSR 52w8

Safety69

Leverage98

Liquidity36

Refinancing37

Combined—

Sentiment9

Analyst Opinions—

Pro Holdings9

Opinion Changes—

Market Pulse16

Profile

CountryUSA

IndustryBiotechnology

SizeSmall

TypePublic Company

ExchangeNASDAQGS

Founded2005

Employees54

Websitexbiotech.com

ISINCA98400H1029

Last UpdateApr 2, 2026

Index & Theme

ImmunologyCardiovascularInflammationNeurologyOncologyInfectious DiseasesBiotechnologyMedical

Description

XBiotech Inc. (‘XBiotech’) operates as a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating a variety of diseases. XBiotech’s True Human monoclonal antibodies are derived from human donors that mount…

Similar Stocks

The companies this stock is ranked against.

Compare Xbiotech with its peers

Regeneron Pharmaceuticals

NSQ:REGN

CountryUSA

IndustryBiotechnology

SizeLarge

Full Stock Analysis →

Spyre Therapeutics

NSQ:SYRE

—

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Forte Biosciences

NAQ:FBRX

—

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Tharimmune

NAQ:THAR

—

CountryUSA

IndustryBiotechnology

SizeX-Small

Full Stock Analysis →

Galectin Therapeutics

NAQ:GALT

—

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Esperion Therapeutics

NMQ:ESPR

CountryUSA

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →